Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.
Pragmatic Trials Across the Cancer Control Continuum
PAR-22-256 (UG3/UH3 - Clinical Trial Required)
Expires November 18, 2025
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility
PAR-22-083 (R01 - Clinical Trial Not Allowed) and PAR-22-084 (R21 - Clinical Trial Not Allowed)
Expires May 8, 2025
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts
PAR-22-161 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
Research Opportunities in Established Cancer Epidemiology Cohort Studies
PAR-22-162 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
Notice of Special Interest: Technology Development for Cancer Control and Population Science Research
Expires December 31, 2024
Exploratory Grants in Cancer Control
PAR-21-341 (R21 - Clinical Trial Optional)
Expires October 9, 2024
Time-Sensitive Obesity Policy and Program Evaluation
PAR-21-305 (R01 - Clinical Trial Not Allowed)
Expires September 11, 2024
Notice of Special Interest: Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
Expires March 9, 2024
Modular R01s in Cancer Control and Population Sciences
PAR-21-190 (R01 - Clinical Trial Optional)
Expires March 8, 2024
Notice of Special Interest: Understanding the Effects of Cancer and Cancer Treatment on Aging Trajectories and Aging Outcomes
Expires January 8, 2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-20-313 (UH2/UH3 - Clinical Trial Not Allowed) and PAR-20-314 (UH3 - Clinical Trials Not Allowed)
Expires October 11, 2023
Notice of Special Interest: Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults
Expires May 08, 2023
View Past Events in the EGRP Video Library
The EGRP video library contains recordings from more than 100 scientific webinars and meetings organized by our program.
Save the date for the 2023 Meeting
The 2023 Cohort Consortium Annual Meeting will be held on October 11-13, 2023 at the NCI Shady Grove campus in Rockville, MD and will be a hybrid in-person/virtual format. More information is forthcoming.
The 2022 Cohort Consortium Annual Meeting was held virtually on November 1-2, 2022. Materials from the meeting such as information about the speakers, the meeting materials, and the recordings will remain available on the website. Please visit the website for more information.
NCI Seeks Associate Director, Epidemiology and Genomics Research Program
Applications will be accepted until March 31, 2023, from innovative leaders interested in serving as the Associate Director of the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population Sciences.
Open Fellowship Opportunities
Please share our fellowship opportunities for training in clinical epidemiology; genetic epidemiology; diet, physical activity, and/or sleep assessment, and communication.
NIH Policy for Data Management and Sharing Effective on January 25, 2023
On January 25, 2023, the Final NIH Policy for Data Management and Sharing (DMS) came into effect for any NIH-funded research that will generate scientific data, regardless of the research grant budget size. EGRP has compiled information from NIH on preparing Data Management and Sharing (DMS) plans, research subject to both the NIH Genomic Data Sharing Policy and the new DMS Policy, and requesting and justifying costs for DMS.
SeqSPACE Webinar Series Adds Five New EventsRegistration is now open for five new Sequencing Strategies for Population and Cancer Epidemiology Studies (SeqSPACE) webinars. Topics include partnering with patients to define the landscape of rare and aggressive sarcomas, data resources for clinical variant interpretation, incorporating common and rare genetic variants into polygenic risk scores of prostate cancer across diverse populations, the human pangenome reference, and prioritizing disease-critical variants, genes, and cell types using genetic and genomic data.
Connect With Us
Subscribe for Updates
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.Email Us